HEADER LIPID BINDING PROTEIN 19-DEC-06 2E59
TITLE CRYSTAL STRUCTURE OF HUMAN MD-2 IN COMPLEX WITH LIPID IVA
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: LYMPHOCYTE ANTIGEN 96;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: MD-2 PROTEIN, ESOP-1;
COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: LY96, ESOP1, MD2;
SOURCE 6 EXPRESSION_SYSTEM: PICHIA PASTORIS;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PPIC9, PPICZA, PPIC6A
KEYWDS INNATE IMMUNITY, LIPID-BINDING, LIPID BINDING PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR U.OHTO,Y.SATOW
REVDAT 7 23-OCT-24 2E59 1 REMARK
REVDAT 6 25-OCT-23 2E59 1 HETSYN
REVDAT 5 29-JUL-20 2E59 1 COMPND REMARK HETNAM LINK
REVDAT 5 2 1 SITE
REVDAT 4 13-JUL-11 2E59 1 VERSN
REVDAT 3 14-APR-09 2E59 1 CONECT
REVDAT 2 24-FEB-09 2E59 1 VERSN
REVDAT 1 26-JUN-07 2E59 0
JRNL AUTH U.OHTO,K.FUKASE,K.MIYAKE,Y.SATOW
JRNL TITL CRYSTAL STRUCTURES OF HUMAN MD-2 AND ITS COMPLEX WITH
JRNL TITL 2 ANTIENDOTOXIC LIPID IVA
JRNL REF SCIENCE V. 316 1632 2007
JRNL REFN ISSN 0036-8075
JRNL PMID 17569869
JRNL DOI 10.1126/SCIENCE.1139111
REMARK 2
REMARK 2 RESOLUTION. 2.21 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.2.0019
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.72
REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.500
REMARK 3 COMPLETENESS FOR RANGE (%) : 78.9
REMARK 3 NUMBER OF REFLECTIONS : 6291
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.208
REMARK 3 R VALUE (WORKING SET) : 0.206
REMARK 3 FREE R VALUE : 0.263
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500
REMARK 3 FREE R VALUE TEST SET COUNT : 297
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.21
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.27
REMARK 3 REFLECTION IN BIN (WORKING SET) : 184
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 31.95
REMARK 3 BIN R VALUE (WORKING SET) : 0.1920
REMARK 3 BIN FREE R VALUE SET COUNT : 8
REMARK 3 BIN FREE R VALUE : 0.2990
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1162
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 123
REMARK 3 SOLVENT ATOMS : 89
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 25.90
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.46
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 1.08000
REMARK 3 B22 (A**2) : 1.08000
REMARK 3 B33 (A**2) : -2.16000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.674
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.300
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.909
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1326 ; 0.011 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1782 ; 1.495 ; 2.059
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 145 ; 6.597 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 53 ;33.862 ;24.340
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 220 ;16.278 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 5 ; 8.002 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 197 ; 0.084 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 921 ; 0.004 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 554 ; 0.259 ; 0.300
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 899 ; 0.344 ; 0.500
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 134 ; 0.233 ; 0.500
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 46 ; 0.255 ; 0.300
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.218 ; 0.500
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 725 ; 4.014 ; 2.000
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1181 ; 6.072 ; 3.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 601 ; 4.389 ; 2.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 601 ; 6.181 ; 3.000
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.40
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 2E59 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-DEC-06.
REMARK 100 THE DEPOSITION ID IS D_1000026241.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 10-OCT-06
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : 5.4
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SPRING-8
REMARK 200 BEAMLINE : BL38B1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RIGAKU JUPITER 210
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7629
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200
REMARK 200 RESOLUTION RANGE LOW (A) : 27.720
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 90.7
REMARK 200 DATA REDUNDANCY : 11.20
REMARK 200 R MERGE (I) : 0.10000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP
REMARK 200 STARTING MODEL: PDB ENTRY 2E56
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 47.18
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG3350, 40MM NA-CITRATE, PH 5.4,
REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4
REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4
REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4
REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4
REMARK 290 7555 Y,X,-Z
REMARK 290 8555 -Y,-X,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.44450
REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 26.39750
REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 26.39750
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 27.72225
REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 26.39750
REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 26.39750
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 83.16675
REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 26.39750
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 26.39750
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 27.72225
REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 26.39750
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 26.39750
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 83.16675
REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 55.44450
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O6 LP5 A 501 O5 LP4 A 601 1.96
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 27 -164.70 -105.44
REMARK 500 ASP A 38 -147.36 43.61
REMARK 500 GLN A 41 -162.33 -113.28
REMARK 500 LYS A 55 4.02 -69.42
REMARK 500 THR A 84 -13.52 68.59
REMARK 500 LYS A 89 150.89 -46.42
REMARK 500 ARG A 96 -128.45 -102.32
REMARK 500 SER A 98 -139.10 44.35
REMARK 500 LYS A 109 113.00 -33.38
REMARK 500 THR A 112 124.54 -38.55
REMARK 500 SER A 141 111.83 -19.14
REMARK 500
REMARK 500 REMARK: NULL
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 2E56 RELATED DB: PDB
REMARK 900 THE SAME PROTEIN
DBREF 2E59 A 17 160 UNP Q9Y6Y9 LY96_HUMAN 17 160
SEQRES 1 A 144 GLU ALA GLN LYS GLN TYR TRP VAL CYS ASN SER SER ASP
SEQRES 2 A 144 ALA SER ILE SER TYR THR TYR CYS ASP LYS MET GLN TYR
SEQRES 3 A 144 PRO ILE SER ILE ASN VAL ASN PRO CYS ILE GLU LEU LYS
SEQRES 4 A 144 GLY SER LYS GLY LEU LEU HIS ILE PHE TYR ILE PRO ARG
SEQRES 5 A 144 ARG ASP LEU LYS GLN LEU TYR PHE ASN LEU TYR ILE THR
SEQRES 6 A 144 VAL ASN THR MET ASN LEU PRO LYS ARG LYS GLU VAL ILE
SEQRES 7 A 144 CYS ARG GLY SER ASP ASP ASP TYR SER PHE CYS ARG ALA
SEQRES 8 A 144 LEU LYS GLY GLU THR VAL ASN THR THR ILE SER PHE SER
SEQRES 9 A 144 PHE LYS GLY ILE LYS PHE SER LYS GLY LYS TYR LYS CYS
SEQRES 10 A 144 VAL VAL GLU ALA ILE SER GLY SER PRO GLU GLU MET LEU
SEQRES 11 A 144 PHE CYS LEU GLU PHE VAL ILE LEU HIS GLN PRO ASN SER
SEQRES 12 A 144 ASN
MODRES 2E59 ASN A 26 ASN GLYCOSYLATION SITE
MODRES 2E59 ASN A 114 ASN GLYCOSYLATION SITE
HET NAG A 801 14
HET NAG A 901 14
HET LP5 A 501 48
HET LP4 A 601 47
HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE
HETNAM LP5 (R)-((2R,3S,4R,5R,6R)-3-HYDROXY-2-(HYDROXYMETHYL)-5-
HETNAM 2 LP5 ((R)-3-HYDROXYTETRADECANAMIDO)-6-(PHOSPHONOOXY)
HETNAM 3 LP5 TETRAHYDRO-2H-PYRAN-4-YL) 3-HYDROXYTETRADECANOATE
HETNAM LP4 2-DEOXY-3-O-[(3R)-3-HYDROXYTETRADECANOYL]-2-{[(3R)-3-
HETNAM 2 LP4 HYDROXYTETRADECANOYL]AMINO}-4-O-PHOSPHONO-BETA-D-
HETNAM 3 LP4 GLUCOPYRANOSE
HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA-
HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO-
HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE
FORMUL 2 NAG 2(C8 H15 N O6)
FORMUL 4 LP5 C34 H66 N O12 P
FORMUL 5 LP4 C34 H66 N O12 P
FORMUL 6 HOH *89(H2 O)
HELIX 1 1 TYR A 102 ALA A 107 5 6
SHEET 1 A 6 TYR A 22 ASN A 26 0
SHEET 2 A 6 ALA A 30 TYR A 36 -1 O ILE A 32 N CYS A 25
SHEET 3 A 6 GLU A 144 HIS A 155 -1 O LEU A 154 N SER A 31
SHEET 4 A 6 LYS A 130 SER A 139 -1 N ALA A 137 O LEU A 146
SHEET 5 A 6 TYR A 75 VAL A 82 -1 N TYR A 75 O ILE A 138
SHEET 6 A 6 MET A 85 ASN A 86 -1 O MET A 85 N VAL A 82
SHEET 1 B 6 TYR A 22 ASN A 26 0
SHEET 2 B 6 ALA A 30 TYR A 36 -1 O ILE A 32 N CYS A 25
SHEET 3 B 6 GLU A 144 HIS A 155 -1 O LEU A 154 N SER A 31
SHEET 4 B 6 LYS A 130 SER A 139 -1 N ALA A 137 O LEU A 146
SHEET 5 B 6 TYR A 75 VAL A 82 -1 N TYR A 75 O ILE A 138
SHEET 6 B 6 ARG A 90 VAL A 93 -1 O ARG A 90 N LEU A 78
SHEET 1 C 3 ILE A 44 ASN A 49 0
SHEET 2 C 3 SER A 57 TYR A 65 -1 O LEU A 60 N ASN A 49
SHEET 3 C 3 VAL A 113 PHE A 121 -1 O VAL A 113 N TYR A 65
SSBOND 1 CYS A 25 CYS A 51 1555 1555 2.02
SSBOND 2 CYS A 37 CYS A 148 1555 1555 2.04
SSBOND 3 CYS A 95 CYS A 105 1555 1555 2.04
LINK ND2 ASN A 26 C1 NAG A 801 1555 1555 1.45
LINK ND2 ASN A 114 C1 NAG A 901 1555 1555 1.43
LINK O6 LP5 A 501 C1 LP4 A 601 1555 1555 1.33
CISPEP 1 ASN A 49 PRO A 50 0 -9.37
CISPEP 2 SER A 141 PRO A 142 0 13.63
CRYST1 52.795 52.795 110.889 90.00 90.00 90.00 P 41 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018941 0.000000 0.000000 0.00000
SCALE2 0.000000 0.018941 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009018 0.00000